Search research articles
Contact Us
Filters
Showing results (51-60 of 461) with videos related to
Page
of 47
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2013
Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis
Mathew B Cox, Nikola A Bowden, Rodney J Scott, et al.
Hereditary Cancer in Clinical Practice
|
March 13, 2010
Deletion Mutations in an Australian Series of HNPCC Patients
Mary McPhillips, Cliff J Meldrum, Rhona Creegan, et al.
Clinical and Translational Medicine
|
June 9, 2020
Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
Kira Groen, Vicki E Maltby, Rodney J Scott, et al.
Plos One
|
February 3, 2017
Promoter Methylation Pattern Controls Corticotropin Releasing Hormone Gene Activity in Human Trophoblasts
Xin Pan, Maria Bowman, Rodney J Scott, et al.
Pharmacogenomics and Personalized Medicine
|
December 17, 2021
Ethnic Diversity of DPD Activity and the <i>DPYD</i> Gene: Review of the Literature
Cassandra White, Rodney J Scott, Christine Paul, et al.
Hereditary Cancer in Clinical Practice
|
March 18, 2010
Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families
Xuan Liu, Hans-Peter Sinn, Hans Ulrich Ulmer, et al.
The Journal of Surgical Research
|
January 30, 2019
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
Joel Petit, Georgia Carroll, Tiffany Gould, et al.
Familial Cancer
|
March 9, 2013
Genetic modifiers of cancer risk in Lynch syndrome: a review
Bente A Talseth-Palmer, Juul T Wijnen, Desma M Grice, et al.
BMC Cancer
|
April 15, 2014
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
Kelly A Avery-Kiejda, Stephen G Braye, John F Forbes, et al.
Multiple Sclerosis and Related Disorders
|
August 18, 2020
Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls
Kira Groen, Vicki E Maltby, Rodney J Scott, et al.
Page
of 47
Search research articles
Search
Showing results (51-60 of 461) with videos related to
Sort By:
Page
of 47
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2013
Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis
Mathew B Cox, Nikola A Bowden, Rodney J Scott, et al.
Hereditary Cancer in Clinical Practice
|
March 13, 2010
Deletion Mutations in an Australian Series of HNPCC Patients
Mary McPhillips, Cliff J Meldrum, Rhona Creegan, et al.
Clinical and Translational Medicine
|
June 9, 2020
Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
Kira Groen, Vicki E Maltby, Rodney J Scott, et al.
Plos One
|
February 3, 2017
Promoter Methylation Pattern Controls Corticotropin Releasing Hormone Gene Activity in Human Trophoblasts
Xin Pan, Maria Bowman, Rodney J Scott, et al.
Pharmacogenomics and Personalized Medicine
|
December 17, 2021
Ethnic Diversity of DPD Activity and the <i>DPYD</i> Gene: Review of the Literature
Cassandra White, Rodney J Scott, Christine Paul, et al.
Hereditary Cancer in Clinical Practice
|
March 18, 2010
Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families
Xuan Liu, Hans-Peter Sinn, Hans Ulrich Ulmer, et al.
The Journal of Surgical Research
|
January 30, 2019
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
Joel Petit, Georgia Carroll, Tiffany Gould, et al.
Familial Cancer
|
March 9, 2013
Genetic modifiers of cancer risk in Lynch syndrome: a review
Bente A Talseth-Palmer, Juul T Wijnen, Desma M Grice, et al.
BMC Cancer
|
April 15, 2014
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
Kelly A Avery-Kiejda, Stephen G Braye, John F Forbes, et al.
Multiple Sclerosis and Related Disorders
|
August 18, 2020
Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls
Kira Groen, Vicki E Maltby, Rodney J Scott, et al.
Page
of 47